Header Logo

Connection

MICHAEL E RYTTING to Immunotherapy, Adoptive

Back to Details
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Immunotherapy, Adoptive.
MICHAEL E RYTTING
Connection Strength
0.093
Immunotherapy, Adoptive
  1. Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia. Leukemia. 2021 11; 35(11):3282-3286.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.